Drugs and Breast Cancer-Related Lymphoedema (BCRL): Incidence and Progression

被引：1
|
作者：
Keeley, Vaughan [1 ,2 ]
机构：
[1] Univ Nottingham, Sch Med, Nottingham, England
[2] Royal Derby Hosp, Lymphedema Dept, Canc Off, Level 3,M&G,Uttoxeter Rd, Derby DE22 3NE, England
来源：
CURRENT BREAST CANCER REPORTS | 2020年 / 12卷 / 04期
关键词：
Breast cancer; Lymphoedema; Drugs; Risk factors; TAXANE-BASED CHEMOTHERAPY; FLUID RETENTION; DOCETAXEL; MECHANISM; THERAPY; IMPACT; EDEMA;
D O I：
10.1007/s12609-020-00379-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Purpose of Review What is the current evidence for the role of drugs as risk factors for the development of breast cancer-related lymphoedema (BCRL) and in exacerbating existing BCRL? What are the mechanisms by which these effects occur? Recent Findings There is now evidence that taking calcium channel blockers (CCBs) during and after breast cancer treatment and receiving docetaxel chemotherapy are risk factors for the development of BCRL. CCBs cause oedema by increasing capillary filtration and docetaxel by inhibiting lymphatic vessel contractions. Ideally, CCBs should be avoided during and after treatment for breast cancer, but alternative options include changing to CCBs with a lower risk of causing oedema. An awareness of the potential role of medications in increasing the risk of BCRL and exacerbating existing BCRL is important in the appropriate management of patients treated for breast cancer.
引用
收藏
页码：230 / 236
页数：7
相关论文
共 50 条
  • [31] Introducing hybrid SPECT/CT imaging in breast cancer-related arm lymphoedema
    Voo, S.
    Heitink, M.
    Janssen, D.
    van Kroonenburgh, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S358 - S359
  • [32] Breast cancer-related lymphoedema and venepuncture: a review and evidence-based recommendations
    Jakes, Adam D.
    Twelves, Chris
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 154 (03) : 455 - 461
  • [33] Prospective surveillance model in the home for breast cancer-related lymphoedema: a feasibility study
    Louise A. Koelmeyer
    Emma Moloney
    John Boyages
    Kerry A. Sherman
    Catherine M. Dean
    Breast Cancer Research and Treatment, 2021, 185 : 401 - 412
  • [34] Prospective surveillance model in the home for breast cancer-related lymphoedema: a feasibility study
    Koelmeyer, Louise A.
    Moloney, Emma
    Boyages, John
    Sherman, Kerry A.
    Dean, Catherine M.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 185 (02) : 401 - 412
  • [35] Variation in lymphatic function may predispose to development of breast cancer-related lymphoedema
    Pain, SJ
    Purushotham, AD
    Barber, RW
    Ballinger, JR
    Solanki, CK
    Mortimer, PS
    Peters, AM
    EJSO, 2004, 30 (05): : 508 - 514
  • [36] Breast cancer-related lymphoedema and venepuncture: a review and evidence-based recommendations
    Adam D. Jakes
    Chris Twelves
    Breast Cancer Research and Treatment, 2015, 154 : 455 - 461
  • [37] L-Dex surveillance of breast cancer-related lymphoedema: A retrospective study
    Koelmeyer, Louise A.
    Borotkanics, Robert
    Winch, Caleb J.
    Prah, Philip
    Alcorso, Jessica M.
    Nakhel, Kristine
    Boyages, John
    CANCER RESEARCH, 2018, 78 (04)
  • [38] Changes to the axillary vein are associated with an increased risk of breast cancer-related lymphoedema
    Pain, S.
    Bainbridge, C.
    Purushotham, A.
    EJC SUPPLEMENTS, 2004, 2 (03): : 144 - 145
  • [39] Screening for breast cancer-related lymphoedema: self-assessment of symptoms and signs
    Svensson, B. J.
    Dylke, E. S.
    Ward, L. C.
    Black, D. A.
    Kilbreath, Sharon L.
    SUPPORTIVE CARE IN CANCER, 2020, 28 (07) : 3073 - 3080
  • [40] Anatomical Theories of the Pathophysiology of Cancer-Related Lymphoedema
    Suami, Hiroo
    CANCERS, 2020, 12 (05)
12345